# Prucalopride Versus Placebo in Gastroparesis

> **NCT02031081** · PHASE2,PHASE3 · COMPLETED · sponsor: **University of Calgary** · enrollment: 15 (actual)

## Conditions studied

- Gastroparesis
- Diabetes Mellitus

## Interventions

- **DRUG:** Prucalopride
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02031081
- **Lead sponsor:** University of Calgary
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2018-06
- **Final completion:** 2018-06
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2020-10-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02031081

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02031081, "Prucalopride Versus Placebo in Gastroparesis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02031081. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*